SPORE in Prostate Cancer
Meet the Team

Dr. Robert Reiter, Principal Investigator of the UCLA SPORE in Prostate Cancer
Leadership
Principal Investigator, UCLA SPORE in Prostate Cancer
Robert Reiter, MD, MBA
Projects
Project II: Developing an N-Terminal Inhibitor of the Androgen Receptor
- Matthew Rettig, MD, Clinical Co-Leader
- Michael Jung, PhD, Basic Co-Leader
Project III: Developing CAR T Cell Therapies to Target Tumor Heterogeneity in Advanced Prostate Cancer
- Owen Witte, MD, Basic Co-Leader
- Stephen Forman, MD, Clinical Co-Leader
- Saul Priceman, PhD, Researcher
Project IV: A Targetable Master Regulator of Lethal Prostate Cancer
- Michael Freeman, PhD, Basic Co-Leader
- Isla Garraway, MD, PhD, Clinical Co-Leader
Cores
Pathology Core
- Anthony Sisk, DO, Core Director
- Jianyu Rao, MD, Core Co-Director
Bioinformatics/Biostatistics Core
- David Elashoff, PhD, Core Director
- Thomas Graeber, PhD, Core Co-Director
- Paul Boutros, PhD, MBA, Core Co-Director,
Administrative Core
- Robert Reiter, MD, MBA, Core Director
- Alexa Hughes, SPORE Coordinator
Organizational Chart
Click to view or download: PDF